Neuroscience Assays
Introduction
Brain biology is a particularly important subject involved in numerous human maladies. Diseases of the brain, collectively called neurological diseases, can have widespread psychological and biological effects, causing harm to the diseased person and potentially others. Unfortunately, due to the invasive nature of brain biopsy collection, the use of brain tissue specimens is quite prohibitive for the identification of biomarkers for disease stratification. Serum neurological disease biomarkers are much more promising but have proven elusive. The notable exception being serum Tau levels for early Alzheimer’s detection. Otherwise, neurological disease biomarkers generally revolve around samples taken from spinal punctures or brains, and spinal cord tissue samples taken postmortem. The limited supply of these sample materials has hampered the ability of current technologies to define novel biomarkers for neurological conditions, in particular for Alzheimer’s and Parkinson’s diseases, complex spectrum disorders such as autism, and neuroinflammation in general.
Neuroscience assays are immunoassays and arrays for the quantitative or semi-quantitative measurement of neurologically important protein biomarkers. RayBiotech provides multiplex arrays, ELISAs, and single molecule protein detection (SIMOA) services for your neuroscience biomarker discovery research.
